Citadel Advisors’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.42M Sell
13,618
-70,168
-84% -$7.32M ﹤0.01% 2982
2025
Q1
$9.77M Sell
83,786
-411,603
-83% -$48M ﹤0.01% 1252
2024
Q4
$41.9M Buy
495,389
+190,707
+63% +$16.1M 0.01% 619
2024
Q3
$27.4M Sell
304,682
-448,555
-60% -$40.3M 0.01% 718
2024
Q2
$60.6M Sell
753,237
-390,407
-34% -$31.4M 0.01% 406
2024
Q1
$91.3M Buy
1,143,644
+54,559
+5% +$4.35M 0.02% 269
2023
Q4
$86.7M Sell
1,089,085
-206,539
-16% -$16.4M 0.02% 287
2023
Q3
$90.6M Buy
1,295,624
+841,306
+185% +$58.8M 0.02% 259
2023
Q2
$32.6M Buy
454,318
+255,297
+128% +$18.3M 0.01% 589
2023
Q1
$12.3M Sell
199,021
-164,720
-45% -$10.2M ﹤0.01% 1171
2022
Q4
$28.1M Sell
363,741
-167,596
-32% -$12.9M 0.01% 703
2022
Q3
$23.7M Buy
531,337
+80,342
+18% +$3.58M 0.01% 735
2022
Q2
$17.3M Buy
450,995
+213,982
+90% +$8.2M ﹤0.01% 923
2022
Q1
$9.81M Sell
237,013
-71,278
-23% -$2.95M ﹤0.01% 1434
2021
Q4
$11.6M Buy
308,291
+224
+0.1% +$8.46K ﹤0.01% 1320
2021
Q3
$10.2M Sell
308,067
-261,738
-46% -$8.63M ﹤0.01% 1424
2021
Q2
$38.4M Buy
569,805
+160,511
+39% +$10.8M 0.01% 611
2021
Q1
$23.2M Sell
409,294
-314,845
-43% -$17.8M 0.01% 842
2020
Q4
$59M Buy
724,139
+492,133
+212% +$40.1M 0.02% 369
2020
Q3
$16.5M Sell
232,006
-225,068
-49% -$16M ﹤0.01% 835
2020
Q2
$37.6M Sell
457,074
-306,420
-40% -$25.2M 0.01% 483
2020
Q1
$44.9M Buy
763,494
+185,851
+32% +$10.9M 0.02% 371
2019
Q4
$59.7M Buy
577,643
+453,636
+366% +$46.9M 0.03% 365
2019
Q3
$2.51M Buy
124,007
+82,473
+199% +$1.67M ﹤0.01% 2188
2019
Q2
$1.07M Buy
41,534
+8,258
+25% +$213K ﹤0.01% 2931
2019
Q1
$474K Buy
+33,276
New +$474K ﹤0.01% 3413
2018
Q3
Sell
-15,581
Closed -$50K 4270
2018
Q2
$50K Buy
+15,581
New +$50K ﹤0.01% 3913
2016
Q4
Sell
-13,171
Closed -$104K 3573
2016
Q3
$104K Buy
+13,171
New +$104K ﹤0.01% 3192